OSI board rejects Astellas' $3.5 billion offer(2)

Mon, 03/15/2010 - 7:17am
The Associated Press

OSI Pharmaceuticals on Monday asked its shareholders to reject a $3.5 billion takeover bid from Astellas Pharma Inc.

On March 2, Astellas made the $52 per share tender offer, a 40 percent per-share premium at the time. The Japanese company also filed a lawsuit in Delaware to prevent OSI from interfering with its offer.

The OSI board of directors, however, said Astellas' offer "does not fully reflect OSI's fundamental, intrinsic value."

Astellas' offer expires March 31.

Shares of OSI Pharmaceuticals Inc. rose 32 cents to $58 in premarket trading. The stock closed at $57.68 Friday.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.